Genomic Characterization of a RET Inhibitor-Resistant
RET
Fusion-Positive Lung Cancer by CSF Cell-Free DNA Hybrid Capture-Based Sequencing
JCO Precis Oncol
.
2020 Nov 16:4:PO.20.00188.
doi: 10.1200/PO.20.00188.
eCollection 2020.
Authors
Noura J Choudhury
1
,
Soo-Ryum Yang
2
,
Maria Arcila
2
,
Abhinita S Mohanty
2
,
Adrienne Boire
3
4
,
Alexander Drilon
1
4
Affiliations
1
Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
2
Department of Pathology, Diagnostic Molecular Pathology Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY.
3
Department of Neurology, Human Oncology and Pathogenesis Program, Brain Tumor Center, Memorial Sloan Kettering Cancer Center, New York, NY.
4
Weill Cornell Medical College, New York, NY.
PMID:
33381675
PMCID:
PMC7768332
DOI:
10.1200/PO.20.00188
No abstract available
Publication types
Case Reports
Grants and funding
P30 CA008748/CA/NCI NIH HHS/United States